Share

    


Home / Search Results

Search Results

Search Publications

Search Again?

Filter By Content Type

Filter By Topic

You searched for:

PowerPoint Presentation Updates in Gynecologic Oncology Agustin A Garcia, MD Professor Louisiana State University Department of Medicine New Orleans, LA Disclosure of Conflicts of Interest Agustin A. Garcia, MD has no relevant financial relationships to disclose. What is new in ovarian cancer (fallopian tube and primary peritoneal carcinoma) • Upfront management …
SO04-2nd-Annual-Oncology-Buyers-&-Resource-Guide
Immunotherapy for Metastatic Renal Cell Carcinoma Timothy M. Kuzel, MD Professor of Medicine and Dermatology Feinberg School of Medicine Northwestern University Chicago,Ilinois Immunotherapy for Metastatic Renal Cell Carcinoma ICLIO 1st Annual National Conference 10.2.15 Philadelphia, Pa. Timothy M. Kuzel, MD Professor of Medicine and Dermatology Feinberg …
Chimeric Antigen Receptor T-cell Therapy for HIV-associated Diffuse Large B-cell Lymphoma: Case Report and Management Recommendations Jeremy Allred1, Kharmen Bharucha2, Can Özütemiz3, Fiona He1, Murali Janakiram1, Joseph Maakaron1, Claire Carrier1, Bartosz Grzywacz4, Veronika Bachanova1. 1) Division of Hematology, Oncology and Transplantation, Department of Medicine, University of Minnesota, Minneapolis …
Genomic alterations associated with early- onset and average-onset colorectal cancer Eric M. Lander, MD Clinical Fellow in Hematology/Oncology Vanderbilt University Medical Center @EricLanderMD Conflicts of interest • None Background • Early-onset colorectal cancer (EOCRC) = Age 60 • Incidence has risen 42% over 20 years • In 10 years, 25% of rectal and …
Presentation Title Event title/location if applicable Evolving Landscape of Perioperative Therapy in Locally Advanced NSCLC TACOS 4/2024 Jiaxin (Jason) Niu, MD, PhD Adjuvant Associate Professor MD Anderson Cancer Center Co-Director of Lung Cancer Program Banner MD Anderson Cancer Center Faculty Disclosure An ineligible company is any entity whose primary business …
Building Meaningful Diversity, Equity, and Inclusivity into Oncology Practice Dr. Richard Lewis Martin III, MD, MPH (he/him/his) Medical Director, Health Equity and Community Engagement Tennessee Oncology President: ACCC - Tennessee Oncology Practice Society (TOPS) Disclosures • Funding • U54 CA0914010 (NCI) • 09/01/2021-08/31/2025 • Meharry-Vanderbilt-TSU Cancer Partnership …
WSMOS 2023 Attendee Roster as of 11.6.xlsx WSMOS 2023 Fall Conference November 17th, 2023 Cedarbrook Lodge Seattle, WA Attendee Roster First Name Last Name Title Account Name Aaron Segel State Advocacy Specialist American Society of Clinical Oncology (ASCO) Shannon Paciorek Meeting Planner Association of Community Cancer Centers (ACCC) Lu Anne Bankert Executive Director Association …
Managing CAR T Cell Toxicity: Strategies and Insights Sai Ravi Pingali MD Associate Professor of Clinical Medicine Houston Methodist Hospital 09/23/2023 Conflict of Interests Attended Ad Board of Cardinal Health From Bench to Bedside: The History and Progress of CAR T Cell Therapy. Mitra A. et. al. Frontiers in Immunology. May 2023. Approved CAR T TherapiesApproved …
Oncology-Buyers-and-Resource-Guide-2007
Carey K. Anders, MD Professor of Medicine Medical Director of the DCBSM; Division Chief NCOA Meeting 8/2023 Updates in Breast Medical Oncology: 2023 Disclosures • Research funding PUMA, Lilly, Merck, Seattle Genetics, Nektar, Tesaro, G1-Therapeutics, ZION, Novartis, Pfizer, Astra Zeneca, Elucida, Caris • Honoraria: Genentech, Eisai, IPSEN, Seattle Genetics, Astra …
PowerPoint Presentation Updates in Melanoma Daniel Johnson, MD Medical Oncologist Deputy Director of Precision Cancer Therapies Program T cellTumor Disclosure of Conflicts of Interest Daniel Johnson, MD, has the following financial relationships to disclose: •Speaker – Astrazeneca, BMS, Pfizer •Advisory Board/Consultant – Nektar Therapeutics Melanoma Subtypes …
Subject Index Full Terms & Conditions of access and use can be found at https://www.tandfonline.com/action/journalInformation?journalCode=uacc20 Oncology Issues ISSN: 1046-3356 (Print) 2573-1777 (Online) Journal homepage: https://www.tandfonline.com/loi/uacc20 Subject Index 1995 (Volume 10) & 1996 (Volume 11) To cite this article: (1996) Subject Index, Oncology Issues, 11:6, …
Slide 1 accc-iclio.org accc-iclio.org accc-iclio.org Management of Immune- related Adverse Events (irAEs) in Patients with NSCLC Marianne Davies, DNP Assistant Professor Yale University School of Nursing Thoracic Oncology Nurse Practitioner Yale Comprehensive Cancer Center accc-iclio.org • Recognize and monitor for adverse events associated with approved …
Immunotherapy-Managing-Immune-Related-Adverse-Events
Immunotherapy-Managing-Immune-Related-Adverse-Events-webinar
Gastrointestinal Oncology Nataliya Uboha, MD, PhD, Associate Professor University of Wisconsin, Carbone Cancer Center Disclosure of Conflicts of Interest Nataliya Uboha, MD, PhD, has the following financial relationships to disclose: • Consulting: QED, Taiho Inc., Incyte, AstraZeneca, Pfizer, Boston Gene, Helsinn. • Research Funding: Taiho Inc, Ipsen, EMD Serono. • Long position …
ICLIO National Conference ICLIO National Conference Jose Lutzky, MD, FACP Director, Melanoma Program Mount Sinai Comprehensive Cancer Center Miami Beach, Florida I-O in Real Time 9.30.16 Philadelphia, Pa. accc-iclio.org Discussion Points • implications with radiology • CNS disease • uptake in your setting • payer criteria and …
Comprehensive Molecular Profiling in Patients with Advanced Biliary Tract Malignancy in a Latinx rich cohort Vidit Kapoor, MD Sylvia Keiser, DO Sukeshi Patel Arora, MD Statisticians: Joel Michalek PhD, Qianqian Liu MS Mays Cancer Center, UT Health San Antonio Vidit Kapoor, MD, has the following financial relationship to disclose: • Stock ownership: Pfizer Disclosure of …
PowerPoint Presentation UPDATES IN Non-Colorectal GI ONCOLOGY SUMA SATTI, MD OCHSNER HEALTH Disclosures • Speaker for Merck, BMS, Elitek, Janssen, Astra Zeneca • Advisory Board for Deciphera Permissions The following slides were shared by authors/presenters and permitted to be presented today ADVANCED HCC …